SCHEMBL7740758

SCHEMBL7740758

CCCCCCCCCCCC(N)C#N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.48
SPHK1 Q9NYA1 2/20 0.45
CYP2D6 P10635 2/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 2/20 0.42
LAP3 P28838 2/20 0.42
PLA2G1B P04054 1/20 0.42
PLA2G2A P14555 1/20 0.42
GMNN O75496 1/20 0.42
POLB P06746 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CETP P11597 1/20 0.42
HTT P42858 1/20 0.42
UBE2N P61088 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2375443 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL7695432 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL219468 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL11481568 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL10502620 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL7694530 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL7691213 1.00 OPRM1 (0.48) OPRM1SPHK1CYP2D6LMNATP53
SCHEMBL5178529 0.98
SCHEMBL219469 0.90
Carbamic Acid SCHEMBL23858115 0.88 GRIK1 (0.46) SPHK1TP53LAP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420593-B2 COMPRISES REACTING IMINODIACETONITRILE WITH ALDEHYDES AND HYDROGEN CYANIDE OR ALKALI METAL CYANIDES; USEFUL AS BIODEGRADABLE COMPLEXING AGENTS FOR ALKALI METAL AND HEAVY METAL IONS BASF AKTIENGESELLSCHAFT (DE) 2002-07-16 US disclosed
US-20010034457-A1 Method for producing long-chain glycine-N,N-diacetic acid derivatives BASF AKTIENGESELLSCHAFT (DE) 2001-10-25 US disclosed
US-6307086-B1 PREPARATION OF LONG-CHAIN SUBSTITUTED NITRILOTRIACETONITRILES FROM IMINODIACETONITRILE, LONG-CHAIN ALDEHYDE AND HCN OR ALKALI METAL CYANIDE OR FROM AN ALPHA-AMINO LONG-CHAIN NITRILE, FORMALDEHYDE AND HCN OR ALKALI METAL CYANIDE BASF AKTIENGESELLSCHAFT (DE) 2001-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034457-A1 Method for producing long-chain glycine-N,N-diacetic acid derivatives SCO2, HAO2, CLIC1 OPRM1 490/4885SPHK1 4139/4885CYP2D6 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.